Benzoylfentanyl
Opioid analgesic
From Wikipedia, the free encyclopedia
Benzoylfentanyl, also known as phenylfentanyl, is an opioid analgesic that is an analog of fentanyl and has been sold as a designer drug.[1][2] In the United States, benzoylfentanyl was first identified in Drug Enforcement Administration drug seizures in 2018.[3]
- CA: Schedule I
- DE: NpSG (Industrial and scientific use only)
- UK: Class A
- US: Schedule I
- Illegal in Sweden and Finland
| |
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C26H28N2O |
| Molar mass | 384.523 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Side effects
Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear.[4] A new wave of fentanyl analogues and associated deaths began in around 2014 in the US, and have continued to grow in prevalence; especially since 2016 these drugs have been responsible for hundreds of overdose deaths every week.[5]
Legal status
In the United States, fentanyl-related substances are Schedule I controlled substances.[6] Benzoylfentanyl was banned in Finland in September 2017,[7] and in Sweden in October 2017.[8]